Literature DB >> 19138167

Substrate specificity of transthyretin: identification of natural substrates in the nervous system.

Márcia A Liz1, Carolina E Fleming, Ana F Nunes, Maria R Almeida, Fernando M Mar, Youngchool Choe, Charles S Craik, James C Powers, Matthew Bogyo, Mónica M Sousa.   

Abstract

Besides functioning as the plasma transporter of retinol and thyroxine, TTR (transthyretin) is a protease, cleaving apoA-I (apolipoprotein A-I) after a phenylalanine residue. In the present study, we further investigated TTR substrate specificity. By using both P-diverse libraries and a library of phosphonate inhibitors, a TTR preference for a lysine residue in P1 was determined, suggesting that TTR might have a dual specificity and that, in addition to apoA-I, other TTR substrates might exist. Previous studies revealed that TTR is involved in the homoeostasis of the nervous system, as it participates in neuropeptide maturation and enhances nerve regeneration. We investigated whether TTR proteolytic activity is involved in these functions. Both wild-type TTR and TTR(prot-) (proteolytically inactive TTR) had a similar effect in the expression of peptidylglycine alpha-amidating mono-oxygenase, the rate-limiting enzyme in neuropeptide amidation, excluding the involvement of TTR proteolytic activity in neuropeptide maturation. However, TTR was able to cleave amidated NPY (neuropeptide Y), probably contributing to the increased NPY levels reported in TTR-knockout mice. To assess the involvement of TTR proteolytic activity in axonal regeneration, neurite outgrowth of cells cultivated with wild-type TTR or TTR(prot-), was measured. Cells grown with TTR(prot-) displayed decreased neurite length, thereby suggesting that TTR proteolytic activity is important for its function as a regeneration enhancer. By showing that TTR is able to cleave NPY and that its proteolytic activity affects axonal growth, the present study shows that TTR has natural substrates in the nervous system, establishing further its relevance in neurobiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138167      PMCID: PMC4153561          DOI: 10.1042/BJ20082090

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Transthyretin in high density lipoproteins: association with apolipoprotein A-I.

Authors:  M M Sousa; L Berglund; M J Saraiva
Journal:  J Lipid Res       Date:  2000-01       Impact factor: 5.922

2.  The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex.

Authors:  A Raz; D S Goodman
Journal:  J Biol Chem       Date:  1969-06-25       Impact factor: 5.157

Review 3.  Transthyretin mutations in hyperthyroxinemia and amyloid diseases.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  2001-06       Impact factor: 4.878

4.  Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.

Authors:  Maria Rosário Almeida; Bárbara Macedo; Isabel Cardoso; Isabel Alves; Gregorio Valencia; Gemma Arsequell; Antoni Planas; Maria João Saraiva
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

5.  Thyroxine transport in choroid plexus.

Authors:  P W Dickson; A R Aldred; J G Menting; P D Marley; W H Sawyer; G Schreiber
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

6.  Transthyretin is involved in depression-like behaviour and exploratory activity.

Authors:  João Carlos Sousa; Catarina Grandela; Javier Fernández-Ruiz; Rosário de Miguel; Liliana de Sousa; Ana Isabel Magalhães; Maria João Saraiva; Nuno Sousa; Joana Almeida Palha
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

7.  Rat transthyretin (prealbumin). Molecular cloning, nucleotide sequence, and gene expression in liver and brain.

Authors:  P W Dickson; G J Howlett; G Schreiber
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

Review 8.  The evolution of transthyretin synthesis in the choroid plexus.

Authors:  Gerhard Schreiber
Journal:  Clin Chem Lab Med       Date:  2002-12       Impact factor: 3.694

9.  Transthyretin, a new cryptic protease.

Authors:  Márcia Almeida Liz; Carlos José Faro; Maria João Saraiva; Mónica Mendes Sousa
Journal:  J Biol Chem       Date:  2004-03-19       Impact factor: 5.157

10.  Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor.

Authors:  Rita Costa; Frederico Ferreira-da-Silva; Maria J Saraiva; Isabel Cardoso
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  14 in total

1.  Structural Analysis of the Effect of a Dual-FLAG Tag on Transthyretin.

Authors:  Mehdi Shirzadeh; Michael L Poltash; Arthur Laganowsky; David H Russell
Journal:  Biochemistry       Date:  2020-03-02       Impact factor: 3.162

2.  Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.

Authors:  Jiong Chen; Long-Jiang Chen; Yun-Lian Xia; Hang-Cheng Zhou; Ren-Bao Yang; Wen Wu; Yin Lu; Li-Wei Hu; Yue Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-02       Impact factor: 4.553

Review 3.  The role of transthyretin in cell biology: impact on human pathophysiology.

Authors:  Joana Magalhães; Márcia Almeida Liz; Jessica Eira
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

4.  Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.

Authors:  Carlos A Ribeiro; Maria João Saraiva; Isabel Cardoso
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

5.  Increased expression of axogenesis-related genes and mossy fibre length in dentate granule cells from adult HuD overexpressor mice.

Authors:  Nora I Perrone-Bizzozero; Daniel C Tanner; Joanna Mounce; Federico Bolognani
Journal:  ASN Neuro       Date:  2011       Impact factor: 4.146

6.  Central transthyretin acts to decrease food intake and body weight.

Authors:  Fenping Zheng; Yonwook J Kim; Timothy H Moran; Hong Li; Sheng Bi
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

7.  Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BAC.

Authors:  Brett A Johnson; Margaret Coutts; Hillary M Vo; Xinya Hao; Nida Fatima; Maria J Rivera; Robert J Sims; Michael J Neel; Young-Jin Kang; Edwin S Monuki
Journal:  Fluids Barriers CNS       Date:  2018-08-16

Review 8.  The interaction of zinc with the multi-functional plasma thyroid hormone distributor protein, transthyretin: evolutionary and cross-species comparative aspects.

Authors:  Kiyoshi Yamauchi
Journal:  Biometals       Date:  2021-03-09       Impact factor: 2.949

9.  The transcriptional landscape of dorsal root ganglia after sciatic nerve transection.

Authors:  Shiying Li; Chengbin Xue; Ying Yuan; Ruirui Zhang; Yaxian Wang; Yongjun Wang; Bin Yu; Jie Liu; Fei Ding; Yuming Yang; Xiaosong Gu
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

10.  Is Transthyretin a Regulator of Ubc9 SUMOylation?

Authors:  Elżbieta Wieczorek; Sylwia Kędracka-Krok; Katarzyna Sołtys; Urszula Jankowska; Rafał Hołubowicz; Justyna Seliga; Andrzej Ożyhar
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.